In Vivo Pharmacology, Evotec
Fraser is responsible for global pharmacology across CNS/pain, inflammation, oncology, infectious disease and cardiometabolic/fibrosis. Prior to joining Evotec in 2015, he was Director of Discovery Services at CRL in Montreal. He has over 25 years of experience in drug discovery and development across different disease areas. Fraser studied pharmacology at Aberdeen University before joining Pfizer in 1990, where he worked on discovery projects in cardiovascular and tissue repair therapy areas.